1World Health Organization. Proposed International Nonproprietary Names: List 59 [J]. WHO Drug Information 1988, (2) : 100.
2World Health Organization. International Nonproprietary Names (INN) Working Group Meeting on Nomenclature for Monoclonal Antibodies (mAb), Geneva, 2008, 242.
3World Health Organization. International Nonproprietary Names (INN) for biological and biotechnological substances (a re- view) [ C]. INN Working Document 05. 179, update Novem- ber 2009.
4World Health Organization. The use of stems in the selection of In- teruational Nonproprietary Names (INN) for pharmaceutical sub-stances [ M]. 2009, WHO/PSM/QSM/2009. 3.
5World Health Organization. Proposed International Nonproprietary Names: Lists 66-111 [J]. WHO Drug Information, vols. 5-28, 1991-2014.
8World Health Organization. The use of stems in the selection of In- ternational Nonproprietary Names (INN) for pharmaceutical sub- stances [M]. 2013, WHO/EMP/RHT/TSN/2003. 1.
